Martingale Asset Management L P Alx Oncology Holdings Inc Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$10.95 - $16.79 $64,758 - $99,296	-5,914 Reduced 14.04%	36,195 $403,000
Q4 2023 Feb 12, 2024	SELL	$4.81 - $15.38 $12,024 - $38,450	-2,500 Reduced 5.6%	42,109 $627,000
Q4 2022 Feb 13, 2023	SELL	$9.51 - $12.95 $28 - $38	-3 Reduced 0.01%	44,609 $502,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $22,048 - $40,560	2,679 Added 6.39%	44,612 $427,000
Q2 2022 Aug 11, 2022	BUY	$5.89 - $19.46 $246,985 - $816,016	41,933 New	41,933 $339,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.